The Role of Fibroscan in Assessment of Liver Fibrosis in Patients With Diabetes Mellitus and Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)

被引：0
|
作者：
Menon, Raakhi [1 ]
Movva, Giri [1 ]
Garza, Devin [1 ]
Butt, Edward [1 ]
Zhang, Julia [1 ]
Khan, Kashif [1 ]
机构：
[1] Univ Texas Med Branch, Galveston, TX USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期
关键词：
D O I：
10.14309/01.ajg.0001036180.44221.bc
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1703
引用
收藏
页码：S1240 / S1240
页数：1
相关论文
共 50 条
  • [41] Prognostic significance of ELF test compared to liver biopsy in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)
    Liguori, Antonio
    D'Ambrosio, Francesca
    Viceconti, Nicholas
    Termite, Fabrizio
    Petrucci, Lucrezia
    Beschi, Riccardo
    Orienti, Marco
    Cardinali, Sara
    Galletti, Simone
    Riccardi, Laura
    Pizzolante, Fabrizio
    De Matthaeis, Nicoletta
    Ainora, Maria Elena
    Zocco, Maria Assunta
    Giustiniani, Maria Cristina
    Marrone, Giuseppe
    Biolato, Marco
    Vecchio, Fabio Maria
    Grieco, Antonio
    Urbani, Andrea
    Sanguinetti, Maurizio
    Gasbarrini, Antonio
    Miele, Luca
    JOURNAL OF HEPATOLOGY, 2024, 80 : S533 - S533
  • [42] Exploratory Role of Flavonoids on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a South Italian Cohort
    Bonfiglio, Caterina
    Tatoli, Rossella
    Donghia, Rossella
    Guido, Davide
    Giannelli, Gianluigi
    ANTIOXIDANTS, 2024, 13 (11)
  • [43] Sarcopenia in metabolic-dysfunction associated steatotic liver disease (MASLD): unraveling its role in cardiovascular damage
    Cespiati, Annalisa
    Lombardi, Rosa
    Sigon, Giordano
    Santomenna, Floriana
    Carlomagno, Matteo
    Couffon, Margaux
    Martino, Beatrice
    Huang, Jian
    Smith, Daniel
    Pisano, Giuseppina
    Oberti, Giovanna
    Forlano, Roberta
    Manousou, Pinelopi
    Petta, Salvatore
    Fracanzani, Anna Ludovica
    JOURNAL OF HEPATOLOGY, 2024, 80 : S466 - S467
  • [44] Association between food insecurity and metabolic dysfunction-associated steatotic liver disease/significant fibrosis measured by fibroscan
    Kim, Donghee
    Perumpail, Brandon J.
    Cholankeril, George
    Ahmed, Aijaz
    EUROPEAN JOURNAL OF NUTRITION, 2024, 63 (03) : 995 - 1001
  • [45] Epidemiology of metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-related liver disease (ALD)
    Wong, Robert J.
    METABOLISM AND TARGET ORGAN DAMAGE, 2024, 4 (04):
  • [46] Comparing imaging modalities in the assessment of fibrosis in metabolic dysfunction-associated steatotic liver disease
    Ravanbakhsh, Naseem
    Browne, Debra
    Weaver, Carly
    Gholikhani, Asal
    Kavarian, Patil
    Mitsinikos, Tania
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2024, 79 (06): : 1192 - 1198
  • [47] Association between food insecurity and metabolic dysfunction-associated steatotic liver disease/significant fibrosis measured by fibroscan
    Donghee Kim
    Brandon J. Perumpail
    George Cholankeril
    Aijaz Ahmed
    European Journal of Nutrition, 2024, 63 : 995 - 1001
  • [48] Poorly controlled pediatric type 1 diabetes mellitus is a risk factor for metabolic dysfunction associated steatotic liver disease (MASLD): An observational study
    Koutny, Florian
    Wiemann, Dagobert
    Eckert, Alexander
    Meyhoefer, Svenja
    Fritsch, Maria
    Pappa, Angeliki
    Wiegand, Susanna
    Weyer, Marc
    Wurm, Michael
    Weghuber, Daniel
    Holl, Reinhard W.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2024, 78 (05): : 1027 - 1037
  • [49] Baseline liver elastography and its longitudinal changes predict liver related outcomes in patients with Metabolic dysfunction Associated Steatotic Liver Disease (MASLD)
    Liguori, A.
    Petrucci, L.
    Pantaleo, F.
    Youssef, F. S. M.
    Marrone, G.
    Biolato, M.
    Pompili, M.
    Grieco, A.
    Gasbarrini, A.
    Miele, L.
    DIGESTIVE AND LIVER DISEASE, 2025, 57
  • [50] The role of FibroScan in the era of metabolic (dysfunction)-associated fatty liver disease
    Yilmaz, Yusuf
    Kaya, Eda
    HEPATOLOGY FORUM, 2023, 4 (02): : I - II
12345